CN106620866A - Preparation method of collagen-hydroxyapatite bracket containing nano zirconium dioxide - Google Patents

Preparation method of collagen-hydroxyapatite bracket containing nano zirconium dioxide Download PDF

Info

Publication number
CN106620866A
CN106620866A CN201610961712.9A CN201610961712A CN106620866A CN 106620866 A CN106620866 A CN 106620866A CN 201610961712 A CN201610961712 A CN 201610961712A CN 106620866 A CN106620866 A CN 106620866A
Authority
CN
China
Prior art keywords
zirconium dioxide
nano zirconium
collagen
hydroxyapatite
dioxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610961712.9A
Other languages
Chinese (zh)
Inventor
王淑芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610961712.9A priority Critical patent/CN106620866A/en
Publication of CN106620866A publication Critical patent/CN106620866A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622Microcapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention relates to a preparation method of a collagen-hydroxyapatite bracket containing nano zirconium dioxide. The preparation method comprises the following steps: carrying out liquid-phase reduction reaction to prepare the nano zirconium dioxide, and unifomrly mixing the nano zirconium dioxide with a collagen-hydroxyapatite solution; freeze-drying with a one-step method and carrying out cross-linking to prepare the collagen-hydroxyapatite bracket, wherein the concentration range of the nano zirconium dioxide is 10mu.g/ml to 50mu.g/ml; the grain diameter of nano zirconium dioxide particles is 10nm to 30nm. According to the bracket provided by the invention, the needed materials are simple, and complicated technical requirements and high-end equipment requirements are not needed; the cost is low and the bracket is easy to popularize; a reasonable nano zirconium dioxide slow releasing system is provided for a wound surface and long-period and effective drug slow release is provided for the wound surface; a drug concentration of the wound surface keeps balanced and is not excessive.

Description

A kind of preparation method of the collagen-hydroxyapatite support containing nano zirconium dioxide
Technical field
The invention belongs to technical field of biological materials, and in particular to a kind of ash of the collagen-hydroxyl phosphorus containing nano zirconium dioxide The preparation method of stone support.
Background technology
Hydroxyapatite and collagen are topmost inorganic and organic principles in nature bone, and all have good life Thing characteristic, but there is different defects again when being used alone, it is difficult to meet requirement of the organizational project to biomaterial performance, with Collagen preferably make use of the caking property of collagen and overcome hydroapatite particles with hydroxyapatite compound Mobility.
Nano zirconium dioxide has excellent conductivity of heat, electric conductivity, surface-active and catalytic performance, in optics, catalysis, micro- The fields such as electronics, bio-sensing, antibacterial have huge using value.The nano zirconium dioxide mealiness of different-shape can be different, As particle diameter is less, narrow particle size distribution spherical nanometer zirconium dioxide powder has good anti-microbial property and electric conductivity.
Due to the high bioactivity of nano zirconium dioxide, when applying it in organizational project, the surface of a wound or mesh are discharged into Mark organ, it preferentially can be captured by the GAP-associated protein GAP in wound exudate or tissue, chlorion and group, cause nano zirconium dioxide Particle is in some position high concentration abnormal aggregations, although can effectively participate in antibacterial, but these superfluous nano zirconium dioxides will be Aggregation, causes the apoptosis of cell in epidermal cell, macrophage, fibroblast, ultimately results in the disunion of the surface of a wound or prolongs Healing late.Generally speaking, immoderate use or uncontrolled release nano zirconium dioxide will certainly run counter to desire, to the surface of a wound Reparation is no advantage.Therefore, safely and effectively using nano zirconium dioxide rational slow-releasing system is needed, for the surface of a wound length is provided Phase effective medicament slow release, keeps the drug concentration of the surface of a wound balanced effective and not superfluous.
The content of the invention
The technical problem to be solved in the present invention is to provide a kind of collagen-hydroxyapatite support containing nano zirconium dioxide Preparation method, is to prepare nano zirconium dioxide by Liquid reduction reaction process, is then well mixed with collagen-hydroxyapatite solution Afterwards one-step method is freezed and is crosslinked preparation becomes Metal pylon, and the novel nano zirconium dioxide prepared with antibacterial, safety is biological Material.
The present invention is achieved by the following technical solutions:
(1) adopting zirconium oxychloride and ammoniacal liquor and adding absolute ethyl alcohol carries out Liquid reduction reaction process preparation nanometer two for dispersant Zirconia sol;Reaction temperature is 30 DEG C -45 DEG C;
(2) heating using microwave in confined conditions of nano zirconium dioxide colloidal sol is reacted, first under 250~350W microwave powers 2~2.5min of reaction, then 2.5~3min is reacted under 100~150W microwave powers, nanometer titanium dioxide zirconium solution is obtained;
(3) NTx albumen ox heel string originated and hydroxyapatite are according to 9:1 mass ratio is dissolved into 0.5mol/L Acetic acid solution in, added as aimed concn with 10ppm and mix 4h after a certain amount of zirconium solution to nanometer titanium dioxide, be subsequently adding total The glutaraldehyde of the 0.5% of quality is simultaneously mixed, and obtains the collagen-hydroxyapatite containing nano zirconium dioxide that mass fraction is 0.5% Solution, by nano zirconium dioxide, collagen-hydroxyapatite solution injects the mould of 4cm × 4cm, freezes 2 hours at -20 DEG C, Then collagen-hydroxyapatite support of the porous containing nano zirconium dioxide for obtaining that thickness is 2mm for 24 hours is freezed.Nano-silica The concentration range for changing zirconium is 10ug/ml-50ug/ml, and the particle diameter of nano zirconium dioxide particle is 10-30nm.
Preferably, the condition of heating using microwave reaction is in the step (2):First react under 300W microwave powers 2.25min, then react 2.75min under 120W microwave powers.
The present invention has the advantages that:
1. the present invention replaces traditional hydro-thermal method to prepare nano zirconium dioxide using microwave-hydrothermal method, with process is simple, With short production cycle, energy-conserving and environment-protective, the features such as having a safety feature.
2. the nano zirconium dioxide particle using the method preparation is spherical in shape, uniform in size, good dispersion.
3. the support material requested of the present invention is simple, without the need for complicated technical requirements and high-end device requirement, low cost, It is easy to spread.
4. support of the present invention provides rational nano zirconium dioxide slow-releasing system for the surface of a wound, provides permanently effective for the surface of a wound Medicament slow release, keep the drug concentration of the surface of a wound balanced effective and not superfluous.
Specific embodiment
The present invention is further illustrated with reference to embodiment.
Embodiment 1
A kind of preparation method of the collagen-hydroxyapatite support containing nano zirconium dioxide is realized by procedure below 's:
(1) adopting zirconium oxychloride and ammoniacal liquor and adding absolute ethyl alcohol carries out Liquid reduction reaction process preparation nanometer two for dispersant Zirconia sol;Plus the addition of absolute ethyl alcohol is the 3% of tetra chlorauric acid quality;Reaction temperature is 40 DEG C;
(2) nano zirconium dioxide colloidal sol stirring 10min is taken, microwave heating treatment (selects the auspicious swan in Beijing under airtight condition HX-300A computer microwaves ultrasound combinatorial compound instrument is microwave source), first 2.25min is reacted under 300W microwave powers, then in 120W 2.75min is reacted under microwave power, nanometer titanium dioxide zirconium solution is obtained;
(3) NTx albumen ox heel string originated and hydroxyapatite are according to 9:1 mass ratio is dissolved into 0.5mol/L Acetic acid solution in, added as aimed concn with 10ppm and mix 4h after a certain amount of zirconium solution to nanometer titanium dioxide, be subsequently adding total The glutaraldehyde of the 0.5% of quality is simultaneously mixed, and obtains the collagen-hydroxyapatite containing nano zirconium dioxide that mass fraction is 0.5% Solution, by nano zirconium dioxide, collagen-hydroxyapatite solution injects the mould of 4cm × 4cm, freezes 2 hours at -20 DEG C, Then the collagen-hydroxyapatite support containing nano zirconium dioxide for obtaining that thickness is 2mm for 24 hours is freezed.Nano zirconium dioxide Concentration range be 10ug/ml-50ug/ml, the particle diameter of nano zirconium dioxide particle is 10-30nm.
Embodiment 2
A kind of preparation method of the collagen-hydroxyapatite support containing nano zirconium dioxide is realized by procedure below 's:
(1) adopting zirconium oxychloride and ammoniacal liquor and adding absolute ethyl alcohol carries out Liquid reduction reaction process preparation nanometer two for dispersant Zirconia sol;Plus the addition of absolute ethyl alcohol is the 3% of tetra chlorauric acid quality;Reaction temperature is 30 DEG C;
(2) nano zirconium dioxide colloidal sol stirring 10min is taken, microwave heating treatment (selects the auspicious swan in Beijing under airtight condition HX-300A computer microwaves ultrasound combinatorial compound instrument is microwave source), first 2.5min is reacted under 250W microwave powers, then in 150W 2.5min is reacted under microwave power, nanometer titanium dioxide zirconium solution is obtained;
(3) NTx albumen ox heel string originated and hydroxyapatite are according to 9:1 mass ratio is dissolved into 0.5mol/L Acetic acid solution in, added as aimed concn with 10ppm and mix 4h after a certain amount of zirconium solution to nanometer titanium dioxide, be subsequently adding total The glutaraldehyde of the 0.5% of quality is simultaneously mixed, and it is 0.5% containing nano zirconium dioxide, collagen-hydroxyapatite to obtain mass fraction Solution, by nano zirconium dioxide, collagen-hydroxyapatite solution the mould of 4cm × 4cm is injected, and is freezed 2 hours at -20 DEG C, Then collagen-hydroxyapatite support of the porous containing nano zirconium dioxide for obtaining that thickness is 2mm for 24 hours is freezed.Nano-silica The concentration range for changing zirconium is 10ug/ml-50ug/ml, and the particle diameter of nano zirconium dioxide particle is 10-30nm.
Although above-mentioned be described to the specific embodiment of the present invention in conjunction with the embodiments, not to present invention protection The restriction of scope, one of ordinary skill in the art should be understood that on the basis of technical scheme, those skilled in the art The various modifications made by creative work need not be paid or deformation are still within protection scope of the present invention.

Claims (2)

1. a kind of preparation method of the collagen-hydroxyapatite support containing nano zirconium dioxide, is characterized in that, step is as follows:
(1) zirconium oxychloride and ammoniacal liquor are adopted and is added absolute ethyl alcohol and is carried out Liquid reduction reaction process for dispersant and prepare nanometer titanium dioxide Zirconium colloidal sol;Reaction temperature is 30 DEG C -45 DEG C;
(2) heating using microwave in confined conditions of nano zirconium dioxide colloidal sol is reacted, is first reacted under 250~350W microwave powers 2~2.5min, then 2.5~3min is reacted under 100~150W microwave powers, nanometer titanium dioxide zirconium solution is obtained;
(3) by ox NTx albumen and shitosan according to 9:1 mass ratio is dissolved in the acetic acid solution of 0.5mol/L, with 10ppm is added to after nanometer titanium dioxide zirconium solution for aimed concn and mixes 4h, be subsequently adding gross mass 0.5% glutaraldehyde simultaneously Mix, obtain mass fraction be 0.5% containing nano zirconium dioxide, collagen-hydroxyapatite solution, by nano zirconium dioxide, Collagen-hydroxyapatite solution injects the mould of 4cm × 4cm, freezes at -20 DEG C 2 hours, then freezes and obtains thickness in 24 hours Spend collagen-hydroxyapatite support of the porous containing nano zirconium dioxide for 2mm.
2. the preparation method of a kind of collagen-hydroxyapatite support containing nano zirconium dioxide according to claim 1, its It is characterized in that:The concentration range of nano zirconium dioxide is 10ug/ml-50ug/ml, and the particle diameter of nano zirconium dioxide particle is 10- 30nm。
CN201610961712.9A 2016-11-04 2016-11-04 Preparation method of collagen-hydroxyapatite bracket containing nano zirconium dioxide Pending CN106620866A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610961712.9A CN106620866A (en) 2016-11-04 2016-11-04 Preparation method of collagen-hydroxyapatite bracket containing nano zirconium dioxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610961712.9A CN106620866A (en) 2016-11-04 2016-11-04 Preparation method of collagen-hydroxyapatite bracket containing nano zirconium dioxide

Publications (1)

Publication Number Publication Date
CN106620866A true CN106620866A (en) 2017-05-10

Family

ID=58821764

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610961712.9A Pending CN106620866A (en) 2016-11-04 2016-11-04 Preparation method of collagen-hydroxyapatite bracket containing nano zirconium dioxide

Country Status (1)

Country Link
CN (1) CN106620866A (en)

Similar Documents

Publication Publication Date Title
Zeng et al. Polydopamine nanoparticle-dotted food gum hydrogel with excellent antibacterial activity and rapid shape adaptability for accelerated bacteria-infected wound healing
Jin et al. An NIR photothermal-responsive hybrid hydrogel for enhanced wound healing
Qi et al. Engineering robust Ag‐decorated polydopamine nano‐photothermal platforms to combat bacterial infection and prompt wound healing
Chen et al. Temperature-regulating phase change fiber scaffold toward mild photothermal–chemotherapy
CN106581766A (en) Preparation method of collagen-hydroxyapatite stent containing nanometer manganese dioxide
CN102926272B (en) Process for preparing biomedical graphene oxide paper
CN1616116A (en) Water gel wound dressing containing radiation sensitive agent and preparing method
Zhang et al. Hydrogel‐based multifunctional dressing combining magnetothermally responsive drug delivery and stem cell therapy for enhanced wound healing
CN106563169A (en) Preparation method for preparing nano silicon dioxide-contained collagen-hydroxyapatite bracket
Zhan et al. Polyphenol-mediated biomimetic mineralization of sacrificial metal-organic framework nanoparticles for wound healing
Jin et al. Dual‐Effective Chronic Wounds Management System through a Monoglyceride Binary Blend Matrix Based Thermal‐Responsive Phase‐Transition Substrate
CN106512092A (en) Method for preparing collagen-hydroxy apatite scaffold containing nano copper phosphide
CN102828271B (en) Hydroxyapatite/PVA (polyvinyl alcohol) fiber material and preparation method thereof
CN106552290A (en) A kind of preparation method of the collagen hydroxyapatite support containing nano-copper sulfide
CN106563168A (en) Preparation method of collagen-hydroxyapatite scaffold containing nanometer titanium dioxide
CN106563165A (en) Preparation method for collagen-hydroxylapatite stent containing nano-cerium dioxide
CN106620866A (en) Preparation method of collagen-hydroxyapatite bracket containing nano zirconium dioxide
CN106581767A (en) Preparation method of collagen-hydroxyapatite stent containing nanometer fluorapatite
Cao et al. A cooling-driven self-adaptive and removable hydrogel coupled with combined chemo-photothermal sterilization for promoting infected wound healing
CN106620862A (en) Preparation method of collagen-hydroxyapatite scaffold containing nano silicon nitride
CN106552292A (en) A kind of preparation method of the collagen hydroxyapatite support containing nano zine oxide
CN106512094A (en) Preparation method of collagen-hydroxyapatite scaffold containing nano nickel phosphide
CN106540331A (en) A kind of preparation method of the collagen hydroxyapatite support containing silver sulfide nanometer particles
CN106512098A (en) Preparing method of collagen-hydroxyapatite support containing nanogold
CN106552291A (en) A kind of preparation method of the collagen hydroxyapatite support containing nano nickel sulphide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170510